{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:20:59Z","timestamp":1792156859238,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Open Access Publication Funds of the Goettingen University"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.omtn.2018.06.001","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T12:17:01Z","timestamp":1531311421000},"page":"443-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effects of RANKL Knockdown by Virus-like Particle-Mediated RNAi in a Rat Model of Osteoporosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Daniel B.","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai O.","family":"B\u00f6ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Deppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Sehmisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt F.","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lemus-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Komrakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.omtn.2018.06.001_bib1","first-page":"14","article-title":"[Osteoporosis: treatment and pharmaceutical care]","author":"Duquet","year":"2014","journal-title":"J.\u00a0Pharm. Belg."},{"key":"10.1016\/j.omtn.2018.06.001_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00104-004-0971-0","article-title":"[Population developments in Germany until 2050]","volume":"76","author":"Osterkamp","year":"2005","journal-title":"Chirurg."},{"key":"10.1016\/j.omtn.2018.06.001_bib3","doi-asserted-by":"crossref","first-page":"213234","DOI":"10.1155\/2013\/213234","article-title":"Age-related changes in trabecular and cortical bone microstructure","volume":"2013","author":"Chen","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.omtn.2018.06.001_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5312\/wjo.v4.i4.207","article-title":"RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases","volume":"4","author":"Yasuda","year":"2013","journal-title":"World J. Orthop."},{"key":"10.1016\/j.omtn.2018.06.001_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","article-title":"The RANKL\/RANK\/OPG pathway","volume":"5","author":"Boyce","year":"2007","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.omtn.2018.06.001_bib6","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00198-011-1740-9","article-title":"Relationship between serum RANKL and RANKL in bone","volume":"22","author":"Findlay","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.omtn.2018.06.001_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.omtn.2018.06.001_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2018.06.001_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2018.06.001_bib10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in\u00a0vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtn.2018.06.001_bib11","doi-asserted-by":"crossref","first-page":"e88272","DOI":"10.1371\/journal.pone.0088272","article-title":"Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fractures","volume":"9","author":"Cumming","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2018.06.001_bib12","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","author":"Bone","year":"2008","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtn.2018.06.001_bib13","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","article-title":"The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study","volume":"26","author":"Papapoulos","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.omtn.2018.06.001_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2018.06.001_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bone.2010.04.594","article-title":"Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density","volume":"47","author":"Genant","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2018.06.001_bib16","unstructured":"European Medicines Agency. (2015). Zusammenfassung des EPAR f\u00fcr die \u00d6ffentlichkeit Prolia [Summary of the European Public Assessment Report for the Public on Prolia] (EMA\/681041\/2015). http:\/\/www.ema.europa.eu\/docs\/de_DE\/document_library\/EPAR_-_Summary_for_the_public\/human\/001120\/WC500093527.pdf."},{"key":"10.1016\/j.omtn.2018.06.001_bib17","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00198-015-3458-6","article-title":"Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics","volume":"27","author":"Popp","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.omtn.2018.06.001_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature07754","article-title":"On the road to reading the RNA-interference code","volume":"457","author":"Siomi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2018.06.001_bib19","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1038\/mtna.2016.15","article-title":"In\u00a0vivo siRNA delivery using JC virus-like particles decreases the expression of RANKL in rats","volume":"5","author":"Hoffmann","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2018.06.001_bib20","first-page":"524","article-title":"The use of virus-like particles for gene transfer","volume":"5","author":"Petry","year":"2003","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.omtn.2018.06.001_bib21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1517\/14712598.2011.583914","article-title":"Human JC virus-like particles as a gene delivery vector","volume":"11","author":"Chang","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2018.06.001_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner."},{"key":"10.1016\/j.omtn.2018.06.001_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-5751-12-12","article-title":"Serotonin: a novel bone mass controller may have implications for alveolar bone","volume":"12","author":"Galli","year":"2013","journal-title":"J.\u00a0Negat. Results Biomed."},{"key":"10.1016\/j.omtn.2018.06.001_bib24","doi-asserted-by":"crossref","first-page":"E1272","DOI":"10.3390\/ijms18061272","article-title":"Osteoblast role in rheumatic diseases","volume":"18","author":"Corrado","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2018.06.001_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bone.2008.04.006","article-title":"Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors","volume":"43","author":"Tat","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2018.06.001_bib26","first-page":"507","article-title":"Postmenopausal osteoporosis and hormone replacement therapy","volume":"95","author":"Gambacciani","year":"2004","journal-title":"Minerva Med."},{"key":"10.1016\/j.omtn.2018.06.001_bib27","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1359\/jbmr.2001.16.8.1416","article-title":"Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones","volume":"16","author":"Ikeda","year":"2001","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtn.2018.06.001_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bone.2008.09.003","article-title":"Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet","volume":"44","author":"Zhang","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2018.06.001_bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bonr.2014.12.001","article-title":"Evaluation of twelve vibration regimes applied to improve spine properties in ovariectomized rats","volume":"7","author":"Komrakova","year":"2014","journal-title":"Bone Rep."},{"key":"10.1016\/j.omtn.2018.06.001_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00774-016-0736-0","article-title":"Comparison of parathyroid hormone and strontium ranelate in combination with whole-body vibration in a rat model of osteoporosis","volume":"35","author":"Hoffmann","year":"2017","journal-title":"J.\u00a0Bone Miner. Metab."},{"key":"10.1016\/j.omtn.2018.06.001_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bone.2012.05.011","article-title":"Effects of 17\u03b2-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-\u03baB ligand","volume":"51","author":"Wang","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2018.06.001_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3349\/ymj.2003.44.3.508","article-title":"A comparison of estrogen and two different doses of calcitonin in ovariectomized rats","volume":"44","author":"Kavuncu","year":"2003","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.omtn.2018.06.001_bib33","doi-asserted-by":"crossref","first-page":"e50301","DOI":"10.1371\/journal.pone.0050301","article-title":"Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts","volume":"7","author":"Seitz","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2018.06.001_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in\u00a0vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2018.06.001_bib35","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.1074\/jbc.M010153200","article-title":"Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis","volume":"276","author":"Collin-Osdoby","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2018.06.001_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejphar.2015.05.048","article-title":"Modulation of osteoblast differentiation and bone mass by 5-HT2A receptor signaling in mice","volume":"762","author":"Tanaka","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.omtn.2018.06.001_bib37","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2013-1597","article-title":"The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension","volume":"98","author":"Bone","year":"2013","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtn.2018.06.001_bib38","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nmeth983","article-title":"Protein complex expression by using multigene baculoviral vectors","volume":"3","author":"Fitzgerald","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2018.06.001_bib39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.omtn.2018.06.001_bib40","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1097\/BRS.0b013e3181afe846","article-title":"Short-term effects of parathyroid hormone on rat lumbar vertebrae","volume":"34","author":"Sehmisch","year":"2009","journal-title":"Spine"},{"key":"10.1016\/j.omtn.2018.06.001_bib41","first-page":"99","article-title":"Effects of urocortin on spine? Results from the rat osteopenia model","volume":"2","author":"Sehmisch","year":"2015","journal-title":"Osteologie"},{"key":"10.1016\/j.omtn.2018.06.001_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1359\/JBMR.050913","article-title":"Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene","volume":"21","author":"St\u00fcrmer","year":"2006","journal-title":"J.\u00a0Bone Miner. Res."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118301288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118301288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:26:43Z","timestamp":1788337603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253118301288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":42,"alternative-id":["S2162253118301288"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2018.06.001","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of RANKL Knockdown by Virus-like Particle-Mediated RNAi in a Rat Model of Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2018.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}